Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma

Author:

Havlínová BarboraORCID,Součková Ilona,Kopřivová Kateřina,Doležal Jiří

Abstract

AbstractDifferentiated thyroid cancer is the most common endocrinological malignancy. Radioiodine treatment has a clear benefit in locally aggressive and metastatic cancers. There are discussions about long-term and acute adverse events.Anti-Müllerian hormone is regarded as the best endocrine marker for evaluating the physiological loss of oocytes in healthy women with regard to age. The impact of radioiodine treatment on anti-Müllerian hormone levels has been more significantly reported in patients over 35 years of age. About reproductive dysfunction, calculations of individual absorbed doses of radioiodine in ovaries after thyroid cancer therapy have not been performed yet. The aim of our ongoing prospective study is to determine serum anti-Müllerian hormone to estimate ovarian reserve for premenopausal women treated with radioiodine and to compare anti-Müllerian hormone levels before and after radioiodine treatment. Predicting radioiodine side effects by evaluating a simple serum biomarker may help to select an appropriate treatment strategy for young women planning pregnancy, specifically in the assessment of ovarian reserve and premature ovarian failure with early onset of menopause.

Funder

Charles University, Faculty of Medicine in Hradec Králové

Publisher

Springer Science and Business Media LLC

Reference15 articles.

1. Wong QHY, Anderson RA. The role of antimullerian hormone in assessing ovarian damage from chemotherapy, radiotherapy and surgery. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):391–8.

2. Jankowska K. Premature ovarian failure. Menopause Review/Przegląd Menopauzalny. 2017;16(2):51–6.

3. Kučera R, Topolčan O, Rumpíková T, Rumpík D, Dostál J. Stanovení anti-Müllerova hormonu u žen [Determination of anti-Müllerian hormone in women]. Ceska Gynekol. 2013;78(3):282–8.

4. Lebl J, Taji EA, Koloušková S, Průhová Š, Šnajderová M, Šumník Z. Dětská endokrinologie a diabetologie. 1 ed. Praha: Galén; 2016. pp. 315–9.

5. Rajpert-De Meyts E, Jørgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of sertoli and granulosa cells. J Clin Endocrinol Metab. 1999;84(10):3836–44.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3